Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, miRNA kits, biochemicals, and cell signaling pathway tools. The company serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. It has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. The company sells its products online. Abcam plc was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom.

Abcam plc

Biotech 365 provides business support services for biotech companies, focusing on fundraising, licensing, and connecting companies with healthcare investors through their global network.

Biotech 365

Abcam provides a range of antibodies, proteins, kits, and reagents for life science research, self-described as helping life scientists worldwide deliver faster breakthroughs.

Metric
Company Name	Abcam plc	Biotech 365
Symbol	ABC
MSH ID	COM:ABCAM	COM:BIOTECH-365
Market	STOCKS	PRIVATE
Sector	Healthcare	Financial Services & Finance
Industry	Biotechnology	Biotechnology Business Services
Country	GB	FR
Stage
Employee Count	1.68K
Website	abcam.com	biotech-365.com
LinkedIn
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	457.01K	68
Web Traffic Growth	0.11	-0.57
Valuation
Raised Capital	256.94M

Metric
Revenue	401.89M
Revenue (LTM)
Revenue (NTM)
Gross Profit	286.19M
EBITDA	60.40M
Operating Income	8.16M
Net Income	5.61M
EPS	0.03
Diluted EPS	0.03
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.71
Operating Profit Margin	0.02
EBITDA Margin	0.15
Net Profit Margin	0.01
Return on Equity	0.01
Return on Assets	0.00
Return on Capital Employed	0.01

COM:ABCAM

Abcam

Last Close

1,103.00

13/12 17:52

Volume Today

3.18M

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	578.45
P/B Ratio	3.88
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple	-2.84

Metric
Days Sales Outstanding
Days Payables Outstanding	51.86
Days Inventory Outstanding	233.95
Operating Cycle	233.95
Cash Conversion Cycle	182.10
Asset Turnover	0.32

Metric
Operating Cash Flow	80.15M
Free Cash Flow	3.95M
Cash Flow to Debt	0.27
Operating Cash Flow/Sales	0.20
Free Cash Flow Yield

Metric
Cash & Equivalents	121.18M
Accounts Receivable
Inventory	74.16M
Goodwill	464.84M
Debt to Capitalization	0.26
Debt to Assets	0.23
Current Ratio	1.13
Quick Ratio	0.51

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.06
R&D to Revenue	0.09
SG&A to Revenue